Peter Olagunju

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Margaret Siegel as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Olagunju:

Company Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Operating Officer Common Stock 0 $1.72 01 Jun 2023 Direct
TCR2 THERAPEUTICS INC. Chief Operating Officer Restricted Stock Unit 0 01 Jun 2023 Direct
TCR2 THERAPEUTICS INC. Chief Operating Officer Stock Option (Right to Buy) 0 $0.7400 01 Jun 2023 Direct

Insider Reports Filed by Peter Olagunju

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923067064-olagunju-peter-2023-06-01 TCR2 THERAPEUTICS INC. 01 Jun 2023 5 $0 4 Chief Operating Officer 01 Jun 2023, 16:27
/report/000089924322039025-olagunju-peter-2022-12-15 TCR2 THERAPEUTICS INC. 15 Dec 2022 2 $0 4 Chief Technical Officer 19 Dec 2022, 16:25
/report/000089924322038384-olagunju-peter-2022-12-09 TCR2 THERAPEUTICS INC. 09 Dec 2022 3 -$5,298 4 Chief Technical Officer 13 Dec 2022, 19:24
/report/000089924322038096-olagunju-peter-2022-12-07 TCR2 THERAPEUTICS INC. 07 Dec 2022 2 -$3,533 4 Chief Technical Officer 09 Dec 2022, 15:42
/report/000089924322037942-olagunju-peter-2022-12-05 TCR2 THERAPEUTICS INC. 05 Dec 2022 2 -$3,531 4 Chief Technical Officer 07 Dec 2022, 18:56
/report/000120919122059882-olagunju-peter-2022-12-01 TCR2 THERAPEUTICS INC. 01 Dec 2022 3 -$1,766 4 Chief Technical Officer 05 Dec 2022, 18:50
/report/000089924322036367-olagunju-peter-2022-11-17 TCR2 THERAPEUTICS INC. 17 Nov 2022 4 $0 4 Chief Technical Officer 18 Nov 2022, 15:22
/report/000120919121069052-olagunju-peter-2021-12-09 TCR2 THERAPEUTICS INC. 09 Dec 2021 1 $0 4 Chief Technical Officer 10 Dec 2021, 15:33
/report/000120919121048305-olagunju-peter-2021-07-26 TCR2 THERAPEUTICS INC. 26 Jul 2021 1 $0 4 Chief Technical Officer 27 Jul 2021, 17:19
/report/000120919121048303-olagunju-peter-2021-07-26 TCR2 THERAPEUTICS INC. 26 Jul 2021 0 $0 3 Chief Technical Officer 27 Jul 2021, 17:16